Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yunnan Baiyao Capsules for postoperative swelling after tibial plateau fracture surgery
ChiCTR2500103963Phase 4Recruiting
- Sponsor
- Beijing Jishuitan Hospital
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in tibial plateau fracture comparing Yunnan Baiyao Capsules group with Control placebo group (2 arms). Primary endpoints: Degree of swelling 14 days after surgery, Swelling improve percent 14 days after surgery and 1 more. Started Mar 2025; status: recruiting.
02
Drugs
Yunnan Baiyao
03
Conditions
tibial plateau fracture
Beyond the preview
Go deeper on ChiCTR2500103963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500103963.